Insufficient scRNA-seq data for expression of ZNF541 at single-cell level.
Insufficient scRNA-seq data for expression of ZNF541 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 98% | 62.92 | 166 / 170 | 56% | 6.10 | 259 / 459 |
breast | 100% | 98.04 | 458 / 459 | 53% | 1.63 | 597 / 1118 |
ovary | 99% | 333.07 | 179 / 180 | 43% | 1.28 | 185 / 430 |
kidney | 90% | 73.70 | 80 / 89 | 52% | 2.32 | 466 / 901 |
skin | 87% | 53.95 | 1579 / 1809 | 39% | 0.92 | 182 / 472 |
adrenal gland | 99% | 450.33 | 255 / 258 | 25% | 0.86 | 57 / 230 |
bladder | 95% | 41.24 | 20 / 21 | 19% | 0.73 | 95 / 504 |
thymus | 99% | 100.32 | 648 / 653 | 13% | 0.23 | 78 / 605 |
intestine | 93% | 81.51 | 899 / 966 | 13% | 0.32 | 66 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.30 | 1 / 1 |
spleen | 100% | 66.03 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 92.16 | 1185 / 1204 | 0% | 0 | 0 / 0 |
brain | 91% | 55.85 | 2416 / 2642 | 5% | 0.10 | 37 / 705 |
prostate | 82% | 27.81 | 202 / 245 | 13% | 0.30 | 66 / 502 |
lung | 79% | 28.78 | 458 / 578 | 13% | 0.41 | 148 / 1155 |
stomach | 71% | 19.35 | 255 / 359 | 20% | 0.45 | 56 / 286 |
tonsil | 0% | 0 | 0 / 0 | 82% | 12.81 | 37 / 45 |
heart | 73% | 41.34 | 625 / 861 | 0% | 0 | 0 / 0 |
esophagus | 60% | 15.28 | 865 / 1445 | 9% | 0.26 | 16 / 183 |
muscle | 63% | 37.22 | 503 / 803 | 0% | 0 | 0 / 0 |
pancreas | 49% | 11.55 | 160 / 328 | 9% | 0.29 | 16 / 178 |
blood vessel | 48% | 12.90 | 640 / 1335 | 0% | 0 | 0 / 0 |
liver | 24% | 6.53 | 54 / 226 | 21% | 0.84 | 86 / 406 |
eye | 0% | 0 | 0 / 0 | 43% | 0.74 | 34 / 80 |
peripheral blood | 34% | 9.51 | 314 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007283 | Biological process | spermatogenesis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF541 |
Protein name | Zinc finger protein 541 |
Synonyms | |
Description | FUNCTION: Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes. Regulates progression of the pachytene stage of meiotic prophase by activating the expression of genes involved in meiosis during spermatogenesis. Maintains the repression of pre-pachytene transcriptional programs, including meiotic double-strand breaks (DSB) formation genes in pachytene spermatocytes and suppresses aberrant DSB formation after mid-pachytene, thus ensuring meiosis progression. . |
Accessions | ENST00000391901.8 [Q9H0D2-3] ENST00000263351.9 ENST00000595558.1 M0R167 H7BXG6 Q9H0D2 |